Cost-Effectiveness of Alternative Thresholds of the Fasting Plasma Glucose Test to Identify the Target Population for Type 2 Diabetes Prevention in Adults Aged >=45 Years

Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years

(2013) Henry S. Kahn   ANNALS OF INTERNAL MEDICINE

Diagnosis and Classification of Diabetes Mellitus

(2012)   DIABETES CARE

Effect of pre-diabetes on future risk of stroke: meta-analysis

(2012) M. Lee et al.   BMJ-British Medical Journal

HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study

(2011) Yoriko Heianza et al.   LANCET

Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults

(2010) Elizabeth Selvin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

(2009)   LANCET

Translating the Diabetes Prevention Program into the Community

(2008) Ronald T. Ackermann et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Impact of Impaired Fasting Glucose on Cardiovascular Disease

(2008) Yamini S. Levitzky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

(2008) Scott D Grosse   Expert Review of Pharmacoeconomics & Outcomes Research